Local view for "http://purl.org/linkedpolitics/eu/plenary/2006-06-13-Speech-2-257"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2006-06-13"^^xsd:date2
dcterms:Is Part Of	lp_eu:Question Time (Commission)2
dcterms:Language	"en"^^xsd:language2
lpv:document identification number	"en.20060613.27.2-257"2
lpv:hasSubsequent	lp_eu:2006-06-13-Speech-2-2582
lpv:speaker	lp:Neelie Kroes2
lpv:spoken text	". Article 152 makes it clear that the organisation and delivery of health services and medical care are the responsibility of Member States, as I mentioned before. Competent national authorities are free to make their own decisions on the pricing and reimbursement of pharmaceutical articles, provided that these decisions are made in a transparent manner and do not create barriers to trade. Member States therefore play a key role, as do the national competition authorities. However, they need to be transparent in the decisions they take in that national context."@en1
lpv:unclassifiedMetadata	"Member of the Commission"1 "Neelie Kroes,"1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph